Breast Cancers With Discordant Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization-Positive (Group 1) and Immunohistochemistry-Negative (0/11) Results Following American Society of Clinical Oncology/College of American Pathologists Guideline.

Saved in:

Bibliographic Details
Title:	Breast Cancers With Discordant Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization-Positive (Group 1) and Immunohistochemistry-Negative (0/11) Results Following American Society of Clinical Oncology/College of American Pathologists Guideline.
Authors:	Wilcock, Diane¹, Jedrzkiewicz, Jolanta^1,2, Cleary, Allison S.^1,2, Beech, Cameron^1,2, Gulbahce, H. Evin^1,2 evin.gulbahce@path.utah.edu
Source:	Archives of Pathology & Laboratory Medicine. Jul2026, Vol. 150 Issue 7, p503-512. 10p.
Database:	Academic Search Ultimate

Description
ISSN:	00039985
DOI:	10.5858/arpa.2025-0490-OA